Regulation of the inflammatory response: Enhancing neutrophil infiltration under chronic inflammatory conditions

Journal of Immunology

Volumn 188, Issue 2, 2012, Pages 844-853

  Bian, Zhen ^a,b   Guo, YaLan ^a   Ha, Binh ^a   Zen, Ke ^b   Liu, Yuan ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

^b NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHITIS; CHRONIC INFLAMMATION; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; EX VIVO STUDY; FEEDBACK SYSTEM; HYPERGLYCEMIA; IMMUNOREGULATION; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INTRACELLULAR SIGNALING; MACROPHAGE FUNCTION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERITONITIS; POSTACUTE PHASE; PRIORITY JOURNAL; TISSUE INJURY;

ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; COLITIS; DISEASE MODELS, ANIMAL; FEEDBACK, PHYSIOLOGICAL; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-17; MICE; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; NEUTROPHILS; PERITONITIS; ZYMOSAN;

EID: 84862915330     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101736     Document Type: Article

References (46)

1. Chen, C. X., I. Soto, Y. L. Guo, and Y. Liu. 2011. Control of secondary granule release in neutrophils by Ral GTPase. J. Biol. Chem. 286: 11724-11733.
2. Liu, Y., D. Merlin, S. L. Burst, M. Pochet, J. L. Madara, and C. A. Parkos. 2001. The role of CD47 in neutrophil transmigration. Increased rate of migration correlates with increased cell surface expression of CD47. J. Biol. Chem. 276: 40156-40166.
3. Zen, K., T. A. Reaves, I. Soto, and Y. Liu. 2006. Response to genistein: assaying the activation status and chemotaxis efficacy of isolated neutrophils. J. Immunol. Methods 309: 86-98. (Pubitemid 43190804)
4. Chanchamroen, S., C. Kewcharoenwong, W. Susaengrat, M. Ato, and G. Lertmemongkolchai. 2009. Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects. Infect. Immun. 77: 456-463.
5. Mowat, A., and J. Baum. 1971. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N. Engl. J. Med. 284: 621-627.
6. Pereira, M. A., P. Sannomiya, and J. G. Leme. 1987. Inhibition of leukocyte chemotaxis by factor in alloxan-induced diabetic rat plasma. Diabetes 36: 1307-1314. (Pubitemid 17163993)
7. Alex, P., N. C. Zachos, T. Nguyen, L. Gonzales, T. E. Chen, L. S. Conklin, M. Centola, and X. Li. 2009. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm. Bowel Dis. 15: 341-352.
8. Okayasu, I., S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya. 1990. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694-702. (Pubitemid 20069706)
9. Salahuddin, M., S. S. Jalalpure, and N. B. Gadge. 2010. Antidiabetic activity of aqueous bark extract of Cassia glauca in streptozotocin-induced diabetic rats. Can. J. Physiol. Pharmacol. 88: 153-160.
10. Wysocki, J., M. Ye, M. J. Soler, S. B. Gurley, H. D. Xiao, K. E. Bernstein, T. M. Coffman, S. Chen, and D. Batlle. 2006. ACE and ACE2 activity in diabetic mice. Diabetes 55: 2132-2139. (Pubitemid 44509989)
11. Cash, J. L., G. E. White, and D. R. Greaves. 2009. Chapter 17. Zymosan-induced peritonitis as a simple experimental system for the study of inflammation. Methods Enzymol. 461: 379-396.
12. Dong, X., and D. Wu. 2006. Methods for studying neutrophil chemotaxis. Methods Enzymol. 406: 605-613. (Pubitemid 43207472)
13. Soria-Castro, I., A. Krzyzanowska, M. L. Pelaéz, J. Regadera, G. Ferrer, L. Montoliu, R. Rodríguez-Ramos, M. Fernández, and S. Alemany. 2010. Cot/tpl2 (MAP3K8) mediates myeloperoxidase activity and hypernociception following peripheral inflammation. J. Biol. Chem. 285: 33805-33815.
14. McLoughlin, R. M., J. Witowski, R. L. Robson, T. S. Wilkinson, S. M. Hurst, A. S. Williams, J. D. Williams, S. Rose-John, S. A. Jones, and N. Topley. 2003. Interplay between IFN-g and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation. J. Clin. Invest. 112: 598-607. (Pubitemid 38056344)
15. Szarka, R. J., N. Wang, L. Gordon, P. N. Nation, and R. H. Smith. 1997. A murine model of pulmonary damage induced by lipopolysaccharide via intra-nasal instillation. J. Immunol. Methods 202: 49-57. (Pubitemid 27104267)
16. Yan, Y., V. Kolachala, G. Dalmasso, H. Nguyen, H. Laroui, S. V. Sitaraman, and D. Merlin. 2009. Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLoS ONE 4: e6073.
17. Alex, P., M. Ye, N. C. Zachos, J. Sipes, T. Nguyen, M. Suhodrev, L. Gonzales, Z. Arora, T. Zhang, M. Centola, S. E. Guggino, and X. Li. 2010. Clcn5 knockout mice exhibit novel immunomodulatory effects and are more susceptible to dextran sulfate sodium-induced colitis. J. Immunol. 184: 3988-3996.
18. Saubermann, L. J., A. Nakajima, K. Wada, S. Zhao, Y. Terauchi, T. Kadowaki, H. Aburatani, N. Matsuhashi, R. Nagai, and R. S. Blumberg. 2002. Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis. Inflamm. Bowel Dis. 8: 330-339.
19. Togawa, J.-I., H. Nagase, K. Tanaka, M. Inamori, A. Nakajima, N. Ueno, T. Saito, and H. Sekihara. 2002. Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. J. Gastroenterol. Hepatol. 17: 1291-1298. (Pubitemid 35356966)
20. Smith, E., M. A. Stark, A. Zarbock, T. L. Burcin, A. C. Bruce, D. Vaswani, P. Foley, and K. Ley. 2008. IL-17A inhibits the expansion of IL-17A-producing T cells in mice through "short-loop" inhibition via IL-17 receptor. J. Immunol. 181: 1357-1364.
21. Wu, S., K. J. Rhee, E. Albesiano, S. Rabizadeh, X. Wu, H. R. Yen, D. L. Huso, F. L. Brancati, E. Wick, F. McAllister, et al. 2009. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15: 1016-1022.
22. Ley, K., E. Smith, and M. A. Stark. 2006. IL-17A-producing neutrophil-regulatory Tn lymphocytes. Immunol. Res. 34: 229-242. (Pubitemid 44195938)
23. Theilgaard-Mönch, K., L. C. Jacobsen, R. Borup, T. Rasmussen, M. D. Bjerregaard, F. C. Nielsen, J. B. Cowland, and N. Borregaard. 2005. The transcriptional program of terminal granulocytic differentiation. Blood 105: 1785-1796. (Pubitemid 40223703)
24. Theilgaard-Mönch, K., B. T. Porse, and N. Borregaard. 2006. Systems biology of neutrophil differentiation and immune response. Curr. Opin. Immunol. 18: 54-60. (Pubitemid 43049648)
25. Botha, A. J., F. A. Moore, E. E.Moore, B. Fontes, A. Banerjee, and V. M. Peterson. 1995. Postinjury neutrophil priming and activation states: therapeutic challenges. Shock 3: 157-166.
26. Brown, K. A., S. D. Brain, J. D. Pearson, J. D. Edgeworth, S. M. Lewis, and D. F. Treacher. 2006. Neutrophils in development of multiple organ failure in sepsis. Lancet 368: 157-169.
27. Nieman, G., B. Searles, D. Carney, U. McCann, H. Schiller, C. Lutz, C. Finck, L. A. Gatto, M. Hodell, and A. Picone. 1999. Systemic inflammation induced by cardiopulmonary bypass: a review of pathogenesis and treatment. J. Extra Corpor. Technol. 31: 202-210. (Pubitemid 30176836)
28. Looney, M. R., B. M. Gilliss, and M. A. Matthay. 2010. Pathophysiology of transfusion-related acute lung injury. Curr. Opin. Hematol. 17: 418-423.
29. Juffermans, N. P. 2010. Transfusion-related acute lung injury: emerging importance of host factors and implications for management. Expert Rev. Hematol. 3: 459-467.
30. Vlaar, A. P., M. J. Schultz, and N. P. Juffermans. 2009. Transfusion-related acute lung injury: a change of perspective. Neth. J. Med. 67: 320-326.
31. Pillay, J., F. Hietbrink, L. Koenderman, and L. P. Leenen. 2007. The systemic inflammatory response induced by trauma is reflected by multiple phenotypes of blood neutrophils. Injury 38: 1365-1372. (Pubitemid 350192398)
32. Ramaiah, S. K., and H. Jaeschke. 2007. Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol. Pathol. 35: 757-766. (Pubitemid 47613608)
33. Biffl, W. L., E. E. Moore, and F. A. Moore. 1995. Gut-derived mediators of multiple organ failure: platelet-activating factor and interleukin-6. Br. J. Hosp. Med. 54: 134-138.
34. Gay, J. C. 1993. Mechanism and regulation of neutrophil priming by platelet-activating factor. J. Cell. Physiol. 156: 189-197. (Pubitemid 23211278)
35. Suzuki, K., M. Yamada, S. Kurakake, N. Okamura, K. Yamaya, Q. Liu, S. Kudoh, K. Kowatari, S. Nakaji, and K. Sugawara. 2000. Circulating cytokines and hormones with immunosuppressive but neutrophil-priming potentials rise after endurance exercise in humans. Eur. J. Appl. Physiol. 81: 281-287. (Pubitemid 30189950)
36. Mitchell, G. B., B. N. Albright, and J. L. Caswell. 2003. Effect of interleukin-8 and granulocyte colony-stimulating factor on priming and activation of bovine neutrophils. Infect. Immun. 71: 1643-1649. (Pubitemid 36368692)
37. Dang, P. M., C. Dewas, M. Gaudry, M. Fay, E. Pedruzzi, M. A. Gougerot-Pocidalo, and J. El Benna. 1999. Priming of human neutrophil respiratory burst by granulocyte/macrophage colony-stimulating factor (GM-CSF) involves partial phosphorylation of p47(phox). J. Biol. Chem. 274: 20704-20708.
38. Yagisawa, M., A. Yuo, S. Kitagawa, Y. Yazaki, A. Togawa, and F. Takaku. 1995. Stimulation and priming of human neutrophils by IL-1 alpha and IL-1 beta: complete inhibition by IL-1 receptor antagonist and no interaction with other cytokines. Exp. Hematol. 23: 603-608.
39. Biffl, W. L., E. E. Moore, F. A. Moore, V. S. Carl, F. J. Kim, and R. J. Franciose. 1994. Interleukin-6 potentiates neutrophil priming with platelet-activating factor. Arch. Surg. 129: 1131-1136.
40. Yamashiro, S., H. Kamohara, J. M. Wang, D. Yang, W. H. Gong, and T. Yoshimura. 2001. Phenotypic and functional change of cytokine-activated neutrophils: inflammatory neutrophils are heterogeneous and enhance adaptive immune responses. J. Leukoc. Biol. 69: 698-704. (Pubitemid 32466406)
41. Torchinsky, M. B., and J. M. Blander. 2010. T helper 17 cells: discovery, function, and physiological trigger. Cell. Mol. Life Sci. 67: 1407-1421.
42. Costa, V. S., T. C. Mattana, and M. E. da Silva. 2010. Unregulated IL-23/IL-17 immune response in autoimmune diseases. Diabetes Res. Clin. Pract. 88: 222-226.
43. Schwarzenberger, P., W. Huang, P. Ye, P. Oliver, M. Manuel, Z. Zhang, G. Bagby, S. Nelson, and J. K. Kolls. 2000. Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J. Immunol. 164: 4783-4789. (Pubitemid 30238080)
44. Schwarzenberger, P., V. La Russa, A. Miller, P. Ye, W. Huang, A. Zieske, S. Nelson, G. J. Bagby, D. Stoltz, R. L. Mynatt, et al. 1998. IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J. Immunol. 161: 6383-6389. (Pubitemid 28536015)
45. Forlow, S. B., J. R. Schurr, J. K. Kolls, G. J. Bagby, P. O. Schwarzenberger, and K. Ley. 2001. Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice. Blood 98: 3309-3314.
46. Stark, M. A., Y. Huo, T. L. Burcin, M. A. Morris, T. S. Olson, and K. Ley. 2005. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22: 285-294. (Pubitemid 40387471)